Company
Overview
Core Values
Executive Leadership
Services
Discovery & Preclinical
Pharmacology Services
Drug Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
Early Clinical Research (Phase 0 – IIa)
Phase 0-IIa
Bioequivalence Studies
Pharmacokinetics / Pharmacodynamics
Bioanalytical Services
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Validated Assays
Global Central Lab
Global Services
Centralized Cardiac Services
ECG Devices
ECG Locations
Quality Assurance
Development & Regulatory Services
Drug Development
Biopharmaceutical Development
Regulatory Affairs
Program Management
Quality Assurance Services
Cardiac Safety Center of Excellence
List A-Z
List by Location
Locations
All Locations
Executive Offices
Discovery & Preclinical
Early Clinical Research
Bioanalytical Services
Global Central Lab
Scientific Library
Case Studies
Podcasts
Posters
Webinars
White Papers
Events
News
News Releases
Media Coverage
Contact Us
Study Participation
Medical Investigators
Careers at MDS
MDS Pharma Services News
June 23, 2009
MDS Pharma Services Begins 3,500th Study With ClinQuick® Electronic Data Acquisition System
June 16, 2009
MDS Pharma Services Bioanalysis Experts to Discuss Characterization of Biosimilars at AAPS National Biotechnology Conference
Upcoming Events
ASBMR 31st Annual Meeting, Denver, CO,
September 11-15, 2009
Home
/
Services
/
Early Clinical Research
/
PK/PD
/
Modeling and Simulation
Modeling and Simulation
MDS Pharma Services’ pharmacokinetic scientists conduct a variety of pharmacokinetic analyses, including PK/PD, clinical trial simulation, sparse sampling strategies, population PK analysis, parametric and nonparametric population PK/PD analysis. In recent years regulatory agencies have encouraged the use of modeling and simulation as methods of accelerating drug development programs. MDS Pharma Services recognizes the need to use pharmaco-statistical models to aid in decision making processes. We can tailor a project to your specific needs and objectives while controlling costs. We have experience in submitting these analyses to regulatory agencies, and working with you to ensure your submission is complete.
Early Clinical Research
Phase I-IIa
Bioequivalence Studies
PK/PD
Study Design and Protocol Development
Data Management
Statistical Analysis
PK/PD Analysis
Medical Writing and Reporting
Modeling and Simulation
Consultation
© 2009 MDS Pharma Services |
Corporate Governance
|
Legal
|
Privacy
|
Site Map